Welcome to our dedicated page for Lumentum Hldgs SEC filings (Ticker: LITE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lumentum’s optical networking and commercial laser business produces some of the most technical disclosures on EDGAR. Revenue swings tied to 3-D sensing demand, customer concentration, and fab utilization make the company’s 10-K daunting, while parsing wafer yield data buried in every 10-Q can feel like reading a physics paper. If you’ve ever asked “How do I read Lumentum’s quarterly earnings report 10-Q filing?” or hunted for “Lumentum insider trading Form 4 transactions,” this page is built for you.
Stock Titan uses AI to turn dense photonics jargon into plain language. Our engine delivers real-time alerts the moment a “Lumentum Form 4 insider transactions real-time” update hits EDGAR, and produces short, digestible summaries so you can grasp wafer capacity shifts, laser segment margins, or any “Lumentum 8-K material events explained” in minutes. Click into an annual report and you’ll see a side-by-side view: the original text plus our “Lumentum annual report 10-K simplified” briefing, complete with charts that map optical component revenue by customer.
Whether you’re modelling demand for data-center coherent optics, tracking “Lumentum proxy statement executive compensation,” or seeking “Lumentum earnings report filing analysis,” you’ll find every document in one place and tagged by theme. Investors typically use our coverage to:
- Monitor “Lumentum executive stock transactions Form 4” before material laser design wins
- Compare segment gross margins across each “Lumentum quarterly earnings report 10-Q filing”
- Review supplier risk disclosures without plowing through hundreds of pages
No more downloading endless PDFs or guessing where CFO Wajid Ali buried the numbers. With understanding Lumentum SEC documents with AI, you can move from filing to decision quickly and confidently.
Lumentum (NASDAQ:LITE) filed a Form 4 revealing director Alan S. Lowe sold 20,000 common shares on 06/26/2025 at $93.47, generating roughly $1.87 million. The trade, executed under a Rule 10b5-1 plan adopted 11/20/2024, reduced his direct stake by about 8% to 230,471 shares.
No derivative transactions were reported. While pre-scheduled, the sale size exceeds materiality thresholds and may influence investor sentiment.
Lumentum Holdings Director Alan S. Lowe has filed a Form 144 indicating intent to sell 20,000 shares of common stock with an aggregate market value of $1,869,400. The planned sale is scheduled for June 26, 2025, through Morgan Stanley Smith Barney on NASDAQ.
The shares to be sold were acquired through multiple transactions between August 2022 and February 2023, including:
- Restricted Stock grants totaling 5,824 shares
- Performance Share awards totaling 14,176 shares
Notable recent trading activity shows Lowe has sold 30,000 shares in the past three months for total gross proceeds of approximately $2.6 million. The filing indicates Lowe is trading under a 10b5-1 plan adopted on November 20, 2024, and affirms no knowledge of undisclosed material adverse information regarding Lumentum's operations.
Director Alan S. Lowe of Lumentum Holdings has reported a significant insider transaction, selling 20,000 shares of Common Stock at $88.47 per share on June 18, 2025. The transaction was executed under a Rule 10b5-1 trading plan established on November 20, 2024.
Following the sale, Lowe maintains direct ownership of 250,471 shares of Lumentum Holdings. The transaction was reported via Form 4 filing, with attorney Jae Kim signing as the authorized representative on June 20, 2025.
- Transaction value: Approximately $1.77 million
- Trading plan: Executed under pre-established Rule 10b5-1 plan
- Position: Director (Non-executive board member)
- Ownership: Direct beneficial ownership
Lumentum Holdings Form 144 filing details a proposed sale of securities by an insider. The filing indicates plans to sell 20,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $1,769,400.
The securities to be sold were acquired through two transactions:
- 8,280 shares as Restricted Stock on August 31, 2022
- 11,720 shares as Performance Shares on August 22, 2022
Recent trading activity by the seller (Alan S. Lowe) in the past 3 months includes three sales on June 4, 2025, totaling 10,000 shares with combined gross proceeds of $835,800. The sale will be executed on the NASDAQ, with an approximate sale date of June 18, 2025. The company currently has approximately 69.4 million shares outstanding.